All News

FDA scrutinizes Byetta, a diabetes drug from Eli Lilly and Amylin, following reports of deaths.

Goal is to identify potential health risks for these groups of women.

Shopko, a discount retailer, donated $1 million.

California was directed by the Federal District Court in Los Angeles to stop the 10 percent cuts in Medi-Cal reimbursement payments to healthcare providers.

The study investigated whether individuals in low-income areas are more strongly influenced by rising prescription drug co-payments than individuals in higher income areas.

The collaboration will study genetic testing and the impact of genetics on the efficacy of prescription drugs.

This year's prescription drug ads are not really impacting consumers.

Consumers can take their unused or unwanted drugs back to their pharmacies.

The card enables users to get discounts on prescriptions at their neighborhood pharmacies.

The partnership will entail a new six-month agreement.

BGS Pharmacy Partners will receive an initial $10 million growth capital commitment from DW Healthcare Partners.

Degree will prepare students to take the national certification examination.

Pharmacies will be consolidated by the end of August.

A research team may have produced a more pure and safer alternative to heparin.

The Pharmacists' Defence Association (PDA) union has launched a stress audit of pharmacists.

They're working together to create an innovative medication therapy management program (MTM) for payers, retailers, pharmacists, and consumers.

Until now, Kansas has used a written logbook system to track the sale of OTC medications containing pseudoephedrine.

Group contends CMS is promoting a less expensive generic substitute.

Students can gain work experience assisting pharmacists with prescriptions and answering patient questions.

This is based on results of a new study reported in Mayo Clinic Proceedings.

A new report from Decision Resources found that Florida leads the pack with most untreated Type 2 diabetics who also have drug coverage.

Physicians' negative experience with Exubera, Pfizer/Nektar's inhaled insulin, may slow adoption of new therapies.

CVS is already the largest drug chain in the country.

The purchase is expected to expand the enrollment of the campus by up to 400 students.

That's one of the conclusions of a new survey report by Decision Resources.

The FDA said patients should monitor the injection site.

The drug is administered as a once-daily tablet.

The school and sports physicals cost $25.